Maravai Lifesciences Holdings (MRVI) Inventory (2020 - 2026)

Maravai Lifesciences Holdings' Inventory history runs 7 years deep, the most recent figure standing at $40.5 million for Q1 2026.

• On a quarterly basis, Inventory fell 18.71% year-over-year to $40.5 million in Q1 2026; TTM through Mar 2026 was $40.5 million, a 18.71% decrease from a year earlier, with the FY2025 full-year figure at $40.5 million, down 19.14% from the prior year.
• Inventory steadied at $40.5 million in Q1 2026 per MRVI's latest filing, from $40.5 million in the prior quarter.
• Across five years, Inventory topped out at $62.4 million in Q3 2022 and bottomed at $40.5 million in Q1 2026.
• The 5-year median for Inventory is $49.8 million (2025), against an average of $49.6 million.
• Across the five-year window, Inventory gained 25.81% in 2022 and dropped 21.28% in 2023, its largest moves.
• Year by year, Inventory stood at $43.2 million in 2022, then grew by 19.11% to $51.4 million in 2023, then fell by 2.56% to $50.1 million in 2024, then fell by 19.14% to $40.5 million in 2025, then dropped by 0.08% to $40.5 million in 2026.
• Per Business Quant, the three latest MRVI Inventory figures stand at $40.5 million (Q1 2026), $40.5 million (Q4 2025), and $45.3 million (Q3 2025).